Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
939.39
1,515.20
1,247.47
1,019.34
1,195.22
1,455.30
1,678.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
939.39
1,515.20
1,247.47
1,019.34
1,195.22
1,455.30
1,678.70
Raw Material Cost
261.73
348.72
375.87
263.33
302.84
392.47
942.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.18
3.00
2.32
2.01
2.17
2.66
10.57
Selling and Distribution Expenses
367.07
618.00
680.09
499.55
569.95
626.01
641.30
Other Expenses
4.64
2.52
8.11
3.93
3.18
2.13
5.13
Total Expenditure (Excl Depreciation)
677.39
994.96
1,139.34
804.14
906.72
1,042.42
1,645.74
Operating Profit (PBDIT) excl Other Income
262
520.2
108.10000000000001
215.2
288.5
412.9
33
Other Income
15.34
22.87
25.72
55.28
1,587.54
17.76
1,741.94
Operating Profit (PBDIT)
285.21
514.81
3.81
285.74
1,884.69
429.11
1,688.60
Interest
2.18
3.00
2.32
2.01
2.17
2.66
10.57
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
677.65
1,166.48
871.61
756.01
892.38
1,062.83
736.08
Depreciation
30.46
30.46
32.94
32.94
29.58
29.58
32.55
Profit Before Tax
252.58
481.35
-31.45
250.78
1,852.94
396.87
1,645.48
Tax
37.55
71.23
2.71
30.06
279.03
64.90
233.29
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
220.94
423.80
-21.16
224.56
1,553.38
374.25
1,425.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
220.94
423.80
-21.16
224.56
1,553.38
374.25
1,425.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.44
-0.73
-14.31
-1.43
-2.07
-2.46
-3.39
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.50
423.07
-35.47
223.13
1,551.30
371.79
1,422.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,940.83
7,522.37
7,099.50
9,009.34
8,784.93
8,217.73
7,843.59
Earnings per share (EPS)
0.29
0.55
-0.03
0.29
2.02
0.49
1.84
Diluted Earnings per share
0.29
0.55
-0.03
0.29
2.02
0.49
1.84
Operating Profit Margin (Excl OI)
25.49%
30.46%
-4.4%
19.38%
22.39%
26.23%
-5.12%
Gross Profit Margin
30.13%
33.78%
0.12%
27.83%
157.5%
29.3%
99.96%
PAT Margin
23.52%
27.97%
-1.7%
22.03%
129.97%
25.72%
84.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -38.00% vs 21.46% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -47.88% vs 1,291.83% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -45.13% vs 2,346.12% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -26.67% vs 30.43% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
939.39
0
939.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
939.39
0
939.39
Raw Material Cost
261.73
0
261.73
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.18
0
2.18
Selling and Distribution Expenses
367.07
0
367.07
Other Expenses
4.64
0.00
4.64
Total Expenditure (Excl Depreciation)
677.39
0
677.39
Operating Profit (PBDIT) excl Other Income
262.00
0.00
262.00
Other Income
15.34
0
15.34
Operating Profit (PBDIT)
285.21
0
285.21
Interest
2.18
0
2.18
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
677.65
0
677.65
Depreciation
30.46
0
30.46
Profit Before Tax
252.58
0
252.58
Tax
37.55
0
37.55
Provisions and contingencies
0
0
0.00
Profit After Tax
220.94
0
220.94
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
220.94
0
220.94
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.44
0
-0.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.50
0
220.50
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,940.83
0
5,940.83
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
25.49%
0%
0.00
25.49%
Gross Profit Margin
30.13%
0%
0.00
30.13%
PAT Margin
23.52%
0%
0.00
23.52%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 93.94 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -38.00% vs 21.46% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -21.40% vs -36.40% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 22.05 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -47.88% vs 1,291.83% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -85.79% vs 479.28% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.99 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -45.13% vs 2,346.12% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -9.16% vs 8.59% in Jun 2025
Quarterly - Interest
Interest 0.22 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -26.67% vs 30.43% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs -80.18% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.49%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
